scispace - formally typeset
A

Andrew T. Meram

Researcher at LSU Health Sciences Center Shreveport

Publications -  16
Citations -  129

Andrew T. Meram is an academic researcher from LSU Health Sciences Center Shreveport. The author has contributed to research in topics: Medicine & DNA damage. The author has an hindex of 5, co-authored 14 publications receiving 64 citations.

Papers
More filters
Journal ArticleDOI

Cystathione β-Synthase Is Increased in Thyroid Malignancies.

TL;DR: It is shown that an H2S-syntheszing enzyme plays a role in thyroid malignancies for the first time, and the data suggest that CBS and NAMPT immunohistochemistry may be useful in differentiating follicular adenomas from follicular carcinomas.
Journal ArticleDOI

Hydrogen Sulfide Is Increased in Oral Squamous Cell Carcinoma Compared to Adjacent Benign Oral Mucosae.

TL;DR: For the first time H2S concentrations within a living human malignancy were measured and compared to adjacent benign oral mucosae and adjacent counterpart benign tissue.
Journal ArticleDOI

Hydrogen sulfide and DNA repair

TL;DR: The role of H 2 S in the DRR and maintenance of genomic stability is reviewed, and it is revealed that H 1 S bioavailability and the ATR kinase regulate each other with ATR inhibition lowering cellular H 2S concentrations, whereas intracellular H2 S concentrations regulate ATR Kinase activity via ATR serine 435 phosphorylation.
Journal ArticleDOI

Molecular Functions of Hydrogen Sulfide in Cancer

TL;DR: The role of H2S in cancer is reviewed, with an emphasis on the molecular mechanisms by which H 2S promotes cancer development, progression, dedifferentiation, and metastasis.
Journal ArticleDOI

The Ataxia telangiectasia-mutated and Rad3-related protein kinase regulates cellular hydrogen sulfide concentrations

TL;DR: It is shown that human colorectal cancer cells carrying biallelic knock-in hypomorphic ATR mutations have lower cellular H2S concentrations than do syngeneic ATR wild-type cells, and all three H1S-synthesizing enzymes show lower protein expression in the ATR hypomorphic mutant cells.